Prof. Dr. James W. Shih

Senior advisor at the Innovax Biotech Inc. Xiamen, China
Professor Emeritus of the School of Public Health, Xiamen University, China

Research interests: Hepatitis viruses and their clinical implications

Prof. Dr. James W. Shih is a senior consultant at Innovax Biotech Inc. Xiamen, China, and Professor Emeritus at the School of Public Health, Xiamen University, China, since 2016. For over 10 years, he was a professor of microbiology at the National Institute of Diagnostics and Vaccine Development in the field of infectious diseases at Xiamen University, China. In 2006, he retired from the National Institutes of Health in Bethesda, USA. During his time at NIH, he was Principal Investigator and Chief of laboratory studies, Division of Infectious Diseases and Chief of the Communicable Virus Laboratory in the Division of Transfusion Medicine, Blood Bank, NIH Clinical Center. Prof. Shih is a microbiologist with over 30 years of experience in the biomedical field.

Most of his career has been related to the development and understanding of hepatitis viruses and their clinical implications. Prof. Shih has led active research programs in virus discovery and in the development and evaluation of hepatitis B and hepatitis C vaccines. He has extensive experience in the development and clinical evaluation of serological and molecular diagnostics for infectious diseases. He also has extensive knowledge and experience in blood safety. 

Since his arrival in China in 2006, he has been involved in the exchange of science and technology between China and other countries. He has worked with WHO and other non-governmental organizations on various vaccine projects. He is currently working on the development of international collaborative projects, including the evaluation of a hepatitis E vaccine.